Prognozy (mln) dla Shin Nippon Biomedical Laboratories, Ltd.
| Okres |
2024-03-31 |
2025-03-31 |
2026-03-31 |
2027-03-31 |
2028-03-31 |
2029-03-31 |
2030-03-31 |
| Przychód (średnia) |
28,295.00 |
32,162.50 |
34,657.50 |
38,612.50 |
42,448.50 |
47,255.50 |
52,861.00 |
| Przychód Δ r/r |
0.00% |
13.67% |
7.76% |
11.41% |
9.93% |
11.32% |
11.86% |
| Przychód (min) |
26,185.37 |
30,744.66 |
32,315.00 |
37,725.00 |
40,577.22 |
45,172.31 |
50,530.70 |
| Przychód (max) |
30,394.63 |
33,580.34 |
37,000.00 |
39,500.00 |
44,319.78 |
49,338.69 |
55,191.30 |
| EBITDA (średnia) |
10,704.65 |
12,167.81 |
13,111.72 |
14,607.99 |
16,059.24 |
17,877.84 |
19,998.53 |
| EBIT (średnia) |
8,667.95 |
9,852.73 |
10,617.05 |
11,828.64 |
13,003.77 |
14,476.35 |
16,193.55 |
| EBIT % |
30.63% |
30.63% |
30.63% |
30.63% |
30.63% |
30.63% |
30.63% |
| Zysk netto (średni) |
4,360.15 |
4,924.85 |
4,573.00 |
5,781.50 |
6,600.00 |
9,800.15 |
10,999.15 |
| Zysk netto % |
15.41% |
15.31% |
13.19% |
14.97% |
15.55% |
20.74% |
20.81% |
| EPS (średnia) |
104.73 |
108.00 |
109.85 |
138.90 |
158.55 |
235.40 |
264.20 |
| Liczba analityków (Przychody) |
2 |
1 |
2 |
2 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
2 |
1 |
1 |
2 |
2 |
1 |
1 |
| symbol |
2395.T |
2395.T |
2395.T |
2395.T |
2395.T |
2395.T |
2395.T |